An increasing number of studies have indicated that FTO can mediate the m6A demethylation of target mRNAs to affect the initiation and progression of CVDs, such as myocardial fibrosis, heart failure, atherosclerosis, and aortic aneurysm (Figure 1). This evidence concerns the gene FTO and heart failure.